Selling a California cannabis business involves much more than finding a buyer. Explore the complete M&A process—from valuation, confidential marketing and LOIs to licensing, real estate, inventory, due diligence and closing.

Most cannabis business emergencies don’t begin as emergencies—they become emergencies when time runs out. Learn why early planning can preserve options when California cannabis operators face regulatory, real estate, ownership, financial or transaction issues.

DEA’s final rescheduling brief argues marijuana can no longer remain in Schedule I. What could Schedule III mean for cannabis M&A, valuations, cash flow, distressed assets and strategic buyers?

Buying a California cannabis business involves far more than purchasing a license. This complete guide explains ownership changes, acquisition structures, due diligence, financing, regulatory approvals, inventory, real estate and closing.

Selling a cannabis business in California is far more complex than selling a traditional business. This comprehensive guide explains every stage of the M&A process, including valuation, confidential marketing, buyer qualification, due diligence, transaction structure, licensing considerations, and closing.

Federal cannabis reform is moving through both administrative and legislative channels. Whether marijuana is rescheduled or ultimately legalized, cannabis businesses should understand how these changes could affect valuations, mergers and acquisitions, capital formation, and long-term strategy.

Glass House, TerrAscend, Tilray, and Chicago Atlantic all made major announcements this week. Together, they tell a larger story about cannabis capital markets, M&A, and industry growth.

EBITDA may tell part of the story, but Free Cash Flow often tells the real story. Learn how sophisticated buyers value cannabis businesses.

Cannabis companies are beginning to reach major U.S. exchanges. Explore what cannabis stock uplisting could mean for investors, M&A, and industry growth.

The cannabis industry is shifting from speculation to execution. Discover why buyers increasingly prefer operating businesses and built infrastructure.

Three major themes emerged from Cannabis Capital Conference 2026: returning capital, hemp beverages, and California’s strategic advantage.

Could California become America's cannabis export hub? Explore how interstate commerce may reshape distribution, real estate, and cannabis M&A.

California cannabis operators are entering a critical DEA registration window under Schedule III medical cannabis rules.

Tilray’s $44 million BrewDog acquisition signals a major shift as a Canadian cannabis company expands into craft beer, positioning itself for future THC beverage markets.

Schedule III is already influencing how cannabis companies think about expansion, research, and consolidation. Early strategic positioning by public operators may have lasting implications for cannabis M&A.